Trends in Androgen Deprivation Therapy Use With Radiation for Intermediate- and High-Risk Prostate Cancer Across the United States

被引：0
|
作者：
Falchook, A. [1 ]
Mohiuddin, J. J. [2 ]
Chen, R. C. [2 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
100
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States
    Falchook, Aaron D.
    Basak, Ramsankar
    Mohiuddin, Jahan J.
    Chen, Ronald C.
    [J]. JAMA ONCOLOGY, 2016, 2 (09) : 1236 - 1238
  • [2] Recent Trends in the Use of Androgen Deprivation Therapy with External Beam Radiation Therapy for Patients with Intermediate- and High-Risk Prostate Cancer
    Yang, D. D.
    Orio, P. F., III
    Nguyen, P. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E151 - E152
  • [3] Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States (vol 2, pg 1236, 2016)
    Falchook, A. D.
    Basak, R.
    Mohiuddin, J. J.
    Chen, R. C.
    [J]. JAMA ONCOLOGY, 2016, 2 (08) : 1099 - 1099
  • [4] A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer
    Hamid, Muhammad
    Heilbrun, Lance K.
    Maier, Jordan
    Devisetty, Kiran
    Connolly, Irene
    Kaufman, Isaac
    Dobson, Kimberlee
    Herroon, Mackenzie K.
    Smith, Daryn
    Sampson, Sandra
    Podgorski, Izabela
    Heath, Elisabeth I.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [5] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer.
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [6] Management trends in the United States for low-, intermediate-, and high-risk prostate cancer.
    Ahmed, Kamran A.
    Kim, Jongphil
    Biagioli, Matthew C.
    Fernandez, Daniel Celestino
    Pow-Sang, Julio
    Poch, Michael Adam
    Wilder, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Intermediate- to high-risk prostate cancer patient treated with radiation therapy
    Raben, David
    Lucia, Scott
    Glode, Michael
    Crawford, E. David
    Kavanagh, Brian
    Raben, Adam
    Ayres, Jennifer
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (09): : 1105 - 1110
  • [8] Brachytherapy and Androgen-Deprivation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer: Not Necessarily an Either/Or Decision
    Castro Mendez, Lucas
    Martell, Kevin
    Crook, Juanita M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3820 - +
  • [9] TRENDS IN USE OF ANDROGEN DEPRIVATION THERAPY WITH RADIATION IN HIGH AND VERY HIGH RISK PROSTATE CANCER PATIENTS
    DeLancey, John
    Matulewicz, Richard
    Ko, Oliver
    Schaeffer, Edward
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E1014 - E1015
  • [10] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
12345